54 professor-computer-science-"https:" "https:" "https:" "https:" "Universidade do Minho CTAC" Fellowship positions at UNIVERSITY OF SOUTHAMPTON
Sort by
Refine Your Search
-
spectrometry–based proteomic approaches, working closely with bioinformaticians to integrate molecular datasets with clinical metadata using advanced computational and systems biology methods, including
-
Clinical research in Mood Disorders The Faculty of Medicine and Hampshire and Isle of Wight Healthcare NHS Foundation Trust are collaborating in a clinical research study, led locally by Professor
-
We are looking to appoint a postdoctoral researcher with experience and expertise in nanoelectronic device fabrication, to be based in the School of Electronics and Computer Science
-
findings at international conferences. Required qualifications and experience: To succeed, you will hold a PhD (or be close to completion) in Computer Science, Applied Mathematics/Statistics, Physics
-
. This is a 3 year fixed term contract in the first instance. An Enhanced DBS Check is required for this role. Visits to Cancer Sciences School are welcomed and can be arranged by contacting Professor Andrew
-
of Electronics and Computer Science at the University of Southampton as part of the group of Prof. Kees de Groot and Dr Ruomeng Huang. This postdoctoral fellowship is part of the EXPRESS (Exploiting Single Source
-
You will join our team at the Optoelectronics Research Centre and work on the Engineering and Physical Sciences Research Council funded project HyMeta: Hyperuniform Disordered Metasurfaces
-
of Physics and Astronomy at the University of Southampton invites applications for a Research Fellow in Observational Astrophysics to work with Professor Manda Banerji on an STFC funded research project
-
a Horizon Europe Pathfinder science-to-technology breakthrough, targeting a paradigm shift in fabricating a novel optically active crystal – rare-earth (RE) doped sapphire (REDS). The EIC-funded
-
postdoctoral scientist to work on our Blood Cancer UK-funded programme developing next-generation, off-the-shelf immunotherapies for acute myeloid leukaemia (AML). This three-year project will harness cytotoxic